Neuronetics (STIM) Misses Q4 EPS by 1c ; Offers Guidance

Neuronetics (NASDAQ: STIM) reported Q4 EPS of ($0.10), $0.01 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $41.77 million versus the consensus estimate of $40.66 million.

GUIDANCE:

Neuronetics sees FY2026 revenue of $160-166 million, versus the consensus of $164.2 million.

For earnings history and earnings-related data on Neuronetics (STIM) click here.

You May Also Be Interested In

• Gulfport Energy and Mobility Global to join S&P SmallCap 600
• JPMorgan Downgrades Astral Ltd (ASTRA:IN) to Neutral
• Goldman Sachs Reiterates Buy Rating on NetEase.com (NTES)